Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofMitoxantrone Injection from Surat, Gujarat, India. Mitoxantrone Injection used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.
Tags: Mitoxantrone Injection manufacturer, Mitoxantrone Injection exporter, Mitoxantrone Injection supplier,and Mitoxantrone Injection, whogmp approved Mitoxantrone Injection manufacturer andsupplier, Mitoxantrone Injection distributor, Mitoxantrone Injection shipper,Mitoxantrone Injection 12.5 ml Mitoxantrone Injection 12.5 mlsupplier,Mitoxantrone Injection 12.5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy Lifescience Mitoxantrone Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Therapeutic Uses and IndicationsMitoxantrone Injection is primarily indicated for acute non-lymphocytic leukemia, hormone-refractory prostate cancer, and certain types of multiple sclerosis. Its ability to suppress cancer cell proliferation and modulate immune responses makes it an important agent in oncology and neurology settings. Treatment should only be initiated under strict medical supervision.
Administration and Dosage InformationThis medication is intended for intravenous use only, provided in sterile 5ml or 10ml glass vials. Dosage depends on patient-specific factors and condition severity, so administration should be carried out by a qualified health professional in a clinical environment. Always discard any remaining solution after a single use to minimize contamination risks.
Quality Assurance and Safety StandardsMitoxantrone Injection is manufactured in Indian GMP-compliant facilities and meets rigorous USP quality criteria. The product is odorless, exhibits a clear blue appearance, and maintains a stable pH level for optimum stability. Careful packaging with a secure stopper and flip-off cap preserves its sterility and safety.
FAQ's of Mitoxantrone Injection:
Q: How should Mitoxantrone Injection be administered?
A: Mitoxantrone Injection is strictly for intravenous administration and must be given by a healthcare professional. It should never be injected intramuscularly, subcutaneously, or orally, as this can cause severe tissue damage.
Q: What medical conditions is Mitoxantrone Injection used to treat?
A: This medication is prescribed for acute non-lymphocytic leukemia, hormone-refractory prostate cancer, and certain forms of multiple sclerosis. The exact indication and regimen are determined by a physician based on individual patient needs.
Q: When should I avoid using Mitoxantrone Injection?
A: Mitoxantrone should not be used in patients with known hypersensitivity to its components or in those with severe myocardial (heart) insufficiency. Always inform your doctor of your full medical history before starting treatment.
Q: Where should Mitoxantrone Injection be stored?
A: Store the vials in a cool, dry place away from light. Conditions that are too warm or damp can affect the medication's quality. Always ensure the storage instructions on the leaflet are followed diligently.
Q: What is the process for using Mitoxantrone Injection?
A: Only a trained healthcare provider should prepare and administer Mitoxantrone Injection. The solution is withdrawn from the sterile vial and delivered through a vein. Any unused portion after opening must be discarded immediately, as the product is for single use only.
Q: What are the benefits of Mitoxantrone Injection therapy?
A: The main benefits include its effectiveness in slowing disease progression in multiple sclerosis and treating certain cancers like leukemia and prostate cancer, under expert guidance. Prompt and precise administration can improve therapeutic outcomes and patient quality of life.